Stockreport

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal [CNBC]

Organon & Co.  (OGN) 
PDF Sun Pharmaceutical will buy all outstanding shares of Organon for $14.00 per share. The acquisition will lift Sun Pharmaceutical's revenues to $ 12.4 billion, ranking [Read more]